Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma
- 1 July 2004
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 59 (3) , 765-781
- https://doi.org/10.1016/j.ijrobp.2003.11.029
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin diseaseCancer, 2002
- EBVD Combination Chemotherapy Plus Low Dose Involved Field Radiation is a Highly Effective Treatment Modality for Early Stage Hodgkin's DiseaseLeukemia & Lymphoma, 2000
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998
- Infradiaphragmatic Hodgkin's Disease: Long Term Results of Combined Modality TherapyLeukemia & Lymphoma, 1996
- Leukemia Following Hodgkin's DiseaseNew England Journal of Medicine, 1990
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASEThe Lancet, 1987
- Morbidity of staging laparotomy in Hodgkin's diseaseThe American Journal of Medicine, 1978
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958